throbber

`
`t_A...-.—-..”...W
`
`0000000
`.......
`.......
`
`:5 7-8 l9!)
`
`HMANDE
`
`......
`
`------
`oooooo
`
`Ide (anti:
`2i destina-
`mt aux
`
`
`03 Lyon
`
`E
`
` Syndrome psychiatrique aigu
`
`et quinolones
`
`
`J. -F. DEFOlN ('), T. DEBONNE ("), M. -O. RAMBOUHG (7.
`J.£%¥MPHW¥?AJBUH¥W£?,AIJME%MUDF1
`*)f?FAYF% DflEUWY"?
`liBERDMfl.
`SAMUSt/CentreAnfi-Poisons. ServiceduDocteurGASEYS- 0....HFIU -51092HEIRBCédex.
`f Lmolatoh‘edeToxicologie-~ServiceduProiosseurH. OHOISYO....-HRU510928EIMSCédex.
`
`‘flPéd‘atrieA--ServiceduProtesseurF. PENNAFOHTE- CHHRJJ. -5109238m6édex.
`
`RESUME : Psychiatric syndrome and quinoione
`Les auteurs rapportent un syndrome psychiatrique aigu complique' d'uun étatde
`mal convulsif et de troubles me'taboliques majeurs nécessitant anticonvulsivantsm-
`traveineux et vena'lation artificialle.
`
`L'évolution était favorable en quelques heures. Le bilan e’tioiogique restait né-
`gatif at scale la spectrometrie de masse permetmit d'identifier une intoxication a la
`Fluméquine. Ceci démom‘re une nouvelle fois la trés grands prudence ne'cessaire
`event do retenir un diagnostic psychiatrique chez l’eniant, ainsi que le faible index
`thérapeutique des quinolones.
`
`Mots-clés : Psychiatric, Intoxication, Fluméquine, Qu'nolones.
`
`SUMMARY
`
`A case of Flumequine poisoning is described ,' a 13-year-old girl was admitted
`for a psychiatric syndrome.
`
`3 hours after, seizures, coma, and metabolic disorders were observed. Infec-
`tious, encephalitic or diabetic diseases were suspected, but not confirmed.
`
`After 12 hours ofa symptomatic treatment, the clinical status improved and the
`patient was discharged. At that time a mblet was foundin herbedroom anda mas
`spectrographic analysis was positive for Flumequine.
`
`This case report is in agreement with previous observations and confirms the
`small therapeutic index ofquinolone, and the absolute necessity to assess carefully
`a psychiatric diagnosis.
`
`' us at Expe'rimentale
`Journal de Toxicologie Cli
`1990, T. 10, n' 7—8—469-4 2
`
`ALCON 2102
`Apotex Inc. v. Alcon Pharmaceuticals, Ltd.
`Case |PR2013-00012
`
`

`

`Syndrome psychiatrique aigu et quinolones
`470
`_____________________._.__..—————-————
`
`Key-words : Psychiatric, Poisoning, Flumequine, Quinolone.
`
`.“a---“
`
`
`
`Le 5 avril 1990, dans l’apres- midi, unejeune fille agée de 13 ans est ad-
`mise aux Urgences pour des episodes itératifs d’agitation avec revulsion
`OCulaire évoluant depuis une heure ; entre ceux-ci, aucun contact ne s’avere
`possible malgré un état de conscience apparemment conserve.
`Elle est transferee dans le service de Pédialrie on elle fait une chute,
`sans signe de localisation on myoclonies associés. Une discrete hyperpnée
`est notée. L’interrogatoire familial ne renouve qu’une notion de dispute ré—
`cente sans prise médicamenteuse. L’intensité du tableau clinique conduit a
`son transfert en Pédopsychiatne u’ois heures apres son admission.
`Elle fait alors une crise comitiale dc type grand mal et an décours, un
`coma, persistant, aréactif a la stimulation douloureuse et sans anomalie pu-
`pillaire (Glasgow 3). Apres sedation des crises par diazépam, intubation et
`ventilation artificielle, elle est transferee dans l’unité de réanimation, tandis
`que sont signalées durant l’apres-midi des mictions volontaires anormale-
`ment fréquentes.
`La persistance de myoclonies avec hyperventilation nécessite rapide—
`ment 1e recours an Nesdonal (30 cg puis 10 cg/h) alors que l’état hémodyna-
`mique. est conserve et que le bilan biologique met en evidence une acidose
`mélabolique majeure (pl-I = 7,04 ; R.A. = 7 mnol/l) avec acidose lactique
`(4,1 mnol/l) et une hyperglycémie (20,1 mnol/l) sans cétose. La nanémie et
`la fonction rénale sont normales et l’hématose sans alteration hypoxémique.
`Un traitement symptomatique est poursuivi (alcalinisation, insulinothé—
`rapie) et le bilan étiologique comportant recherche toxicologique (Salicylés,
`Phénothiazines‘, Imipraminiques, Benzodiazépines, Carbamates), recherche
`d’un accident cerebral (tomodensitographie et artériographie cérébrales) et
`bilans infectieux (ponction lombaire et prélevements bactériologiques) s’a-
`verent négatifs.
`Au milieu de la nuit, soit 10 heures apms son admission, on observe le
`retour a un état de conscience satisfaisant avec une discrete agitation persi—
`stante. Dans la matinee du 6 avril 1990 (16 heures apres l‘admission), l’ex-
`tubation est réalisée. L’examen neurologique est alors sn'ictement normal.
`Elle quitte l’unité de reanimation pour-[e service'de Pediatric ; ses pa-
`rents nous apportent alors un comprimé non identifié retrouvé dans sa cham-
`bre.
`
`L’analyse en spectrometric de masse identifiera la fluméquine avec une
`concentration de 61 mg/l (dosage bacteriologique) sur le prélevement san-
`gain effectue a l‘acmé de la symptomatologie clinique (En dosage chroma.
`tographique une prise de 400 mg entraine un pic plasmatique de 16,9 rug/l)-
`
`
`
`

`

`inolones
`
`J.—F. Defoin at Coll.
`
`.
`
`471
`
`Cette jeune fille quittera le service de Pédiatrie apres qu’un electroen-
`céphalogramme ait formellement éliminé un terrain comitial sons-Jaceut et
`apres avoir, lors d’un entretien medical, confnmé l’ingestion de 5 compri-
`més de fluméquine.
`
`COMMENTAIRES
`
`La littérature fait état de quelques cas d’intoxications a la fluméquine
`avec des doses massives dans un but suicidaire (2-3-5) ou par simple surdo—
`sage (1-5) ; ceci le plus souvent chez dejeunes patientes de moins de 30 ans.
`A postériori, 1e tableau clinique et biologique apparait comme patho-
`gnomonique (les surdosages aigus a la fluméquine qui associent habituelle—
`ment des signes neuropsychiatriques, une acidose metabolique, une hyper-
`-
`pnée, des troubles de la regulation glycémique avec ou sans cétose, et des
`vomissements frequents.
`Le traitement de ces intoxications est symptomatique (anticonvulsi~
`vants, alcalinisation, insulinothérapie, ventilation artificielle) et l’évolution
`le plus souvent rapidement favorable sans séquelle.
`None observation est en accord avec les données de la linérature bien
`que les vomissements et la cétose soient absents ici.
`Elle permet cependant d’attirer l’attention sur quelques points :
`— la nécessité d’unbilan biologique minimum devant tout tableau psy-
`chiatrique aigu (1’installation brutale,
`— l’aide au diagnostic que represente la recherche minitieuse, notam—
`ment dans l’entourage, (1e médicaments ou toxiques devant des tableaux cli-
`niques inexpliqués,
`-
`— l’apport indiscutable, pour l’identification, _de la spectrometric de
`masse,
`,
`'
`:
`—.- 1e faible index thérapeutique, ainsi que l'extréme sensibilité indivi-
`duelle vis-a-vis de cette classe thérapeutique.
`'
`Ce dernier point, déja souligné par les publications antérieures (4-5-6),
`est corroboré d’une part par ce nouveau cas avec une prise équivalente a tune
`double posologie journaliere ; on observe pourtant une concentration plas-
`matique a pres de quatre fois la normale (16,9 mg/l apres 400 mg pour un
`dosage chromatographique). Les autres cas recensés par notIe Centre Anti-
`Poisons confirment ces données.
`'
`En effet, depuis 1983, dix autres cas ont été répertoriés ; cinq furent
`symptomatiques avec presence dc signes neuropsychiatriques pour des
`doses ingérées allant de 1,6 g a 8 g.
`
`A
`
`s est ad-
`Evulsion
`s’avere
`
`e chute,
`perpnée
`pute ré-
`)nduit a
`
`)urs, un
`alie pu—
`Iation et
`
`1, tandis
`ormale-
`
`rapide—
`iodyna—
`acidose
`actique
`emie et
`
`Emique.
`
`iinothé-
`licylés,
`:herche
`
`ales) et
`es) s’a-
`
`serve le
`
`n persi-
`t), l’ex-
`)rmal.
`
`sec pa—
`1cham_
`
`V60 une
`2m San.
`
`throma-
`9mg/1).
`
`l
`
`

`

`472
`
`Syndrome psychiatrique aigu at quinolones
`
`CONCLUSION
`_ _ .___
`Un bilan biologique minimum et un interrogatoire minutieux dc l’en—
`tourage apparaissent indispensablm devant tout tableau psychiatrique aigu
`(1’installation brutale chez un sujetjusque-la indemne dc tout trouble.
`De méme son: indiSpensablw avec cette classe thérapeutique un Strict
`reSpectdo: posologies etde leur repartitionjomnaliére, ainsiqu’une,adapta-
`tion de ces posologies au terrain.
`Un regain d’allention apparait
`nouvelles quinolones qui pounaientconduire a dc tels effets se
`Ion les susceptibilités individuelles, etced’autant quecettainesd’Ientreelles
`bénéficient de modalités d’administration particuliérw (monodose).
`
`BIBLIOGRAPHIE
`Acido-cétose ct hyperglycé—
`.,
`.,
`mic réversiblu apxés absorption dc Fluméquine. R616 dc font“ doses chez. l‘aclulte non
`diabétique. Presse Med, 1980. 9. 636.
`2 - BOLESJ.M., GEN1'RICA., Gm M., Comm 6.. WC,MIL:
`Intoxication massive i laFluméquine. Presse Med, 1985, 14. 1668.
`M., Gamma A., SCI-[EYDECKER 1L. :
`3 - Gown!) 6., Pannaz C., Roma 6.. Bows J.
`Apropos d’un nwveau cas d'intoxication ilaFluméquinc. Conv. Med, 1984, 3. 439—440.
`4 - GAILAND M.C., Dunn! F., LULLB 1.13.. 1011me I. : Fluméquine ct effets sc-
`condaircs nemologiqucs centraux. B. Med. Légale at Tmica, 1979, 22, 615-617.
`. Iouvs-Basrm M.H., Room B, JOUGLARD J. : Effets indésira-
`'
`antibactériens urinaires. Thérapie 1982, 37, 481—487.
`6 - HANNEDOUCHET., GODIM M.,m LP. : Les effets secondaires dcs médica—
`meats umpour 1c traitemcnt des infections admires. Magic 1983, 38, 281—293.
`
`
`
`NOTULE
`
`Concours Médical - 37 rue de Bailefond - 75441 Paris Cédex 09
`
`19janvier 1991
`
`[267]
`
`lectives dans lc cadre du tabac.-
`as, rapport: 25 a 30 milliaxds
`ll rappelle que ce secteur em loic 6.0)0 5 7.000
`dc francs par an au Minister: du udgct. lcs publicitau’es consacrcnt aujourd‘hui pies d‘un
`milliard dc francs par an au tabac, ct i1 montre la difficullé de faire passer unc idéc généralc
`de santé publique dams la population.
`
`
`
`** TOTAL PAGE. 06 **
`
`

`

`Acute
`
`Psychiatric
`
`Quinolones
`
`Syndrome
`
`and
`
`1—P1Luuuqu(n,it[MEBOAunE(n,A4—o.AMALBOLU«}(®,J;SERAiuqu(n,A4.BLUUUET(b
`M. JA USSA UD (*), R. BERTA ULT (*), R. FAY (* *), B. DIGEON (* * *)
`
`(*) SAMU 51/CentreAnti-Poisons [“Poison Control Center”] 7 Department of Dr. G.A. SEYS 7 C.H.R.U. 7 51092 REIMS CédeX.
`(**) Laboratory of Toxicology 7 Department of Professor H. CHOISY 7 C.H.R.U. 7 51092 REIMS CedeX.
`(***) Pediatrics A 7 Department of Professor F. PENNAFORTE 7 C.H.R.U. 7 51092 REIMS Cedex.
`
`SUMMARY: Psychiatric Syndrome and Quinolone
`The authors report an acute psychiatric syndrome complicated with convulsive status
`epilepticus and major metabolic disorders requiring intravenous anticonvulsants and mechanical
`ventilation.
`
`The outcome was favorable in a few hours. The etiological assessment was negative and only
`mass spectrometry allowed identification ofFlumequine intoxication. This demonstrates once again
`the extreme caution necessary before adopting a psychiatric diagnosis in children, as well as the
`low therapeutic index ofquinolones.
`
`Keywords: psychiatric, intoxication, flumequine, quinolones.
`
`SUMMARY
`
`Acmoffiumaqufizepoisarmgisdascrflndm 13-yaar-aidgfiwasadnitted
`farapsybmtficsyndmme.
`
`3hoursaftenseizums. commandmembaticcfisardersmabserwd. Infec-
`fious, emphaliticonfiabaficdisaammmsuspamd, burnotamfinnad.
`
`Altar fEhaumafa aymptmafic #aamm, the Wealmm mmwdandtha
`paflentwascfisdvarged Airbatflmaatabhtwasiuundmharbedrmnarflamas
`WOW was posifiw bf Flumoquina.
`miscase rapaflis inagreemon!‘ M'h‘rpravious obssmfions WW3 the
`small flurapwnb indsxoqumlano, and the absolute necessity a: assess mafidiy
`apsyehiarrlcdiagrmls
`
`Journal de Toxicologie Clinique et Expérimentale
`1990, Vol. 10, No. 7-8 — 469-472
`
`

`

`470
`
`Acute Psychiatric Syndrome and Quinolones
`
`Keywords: Psychiatric, Poisoning, Flumequine, Quinolone.
`
`In the afternoon of April 5, 1990, a 13-year-old girl was admitted to the ER for recurrent
`episodes of agitation with ocular revulsion lasting for one hour; between the episodes, no
`connection proved possible despite the fact she maintained an apparent state of consciousness.
`
`She was transferred to the Pediatric Department where she suffered a fall without an associated
`localization sign or myoclonus. Discrete hyperventilation was noted. Questioning of the family
`revealed only a glimpse into a recent dispute without the taking of any medication. The intensity of
`the clinical picture led to her transfer to Pediatric Psychiatry three hours after her admission.
`
`She then had a grand mal-type seizure that gave way to a persistent coma, unresponsive to
`painful stimulation and without a pupillary anomaly (Glasgow 3). Following sedation of the
`seizures with diazepam, intubation and mechanical ventilation, she was transferred to the ICU,
`while abnormally frequent voluntary urination in the afternoon was reported.
`
`The persistence of myoclonus with hyperventilation quickly required the use of Nesdonal (30
`cg then 10 cg/h), while her hemodynamic status was maintained and the biological assessment
`revealed major metabolic acidosis (pH = 704; RA. = 7 mnol/ 1) with lactic acidosis (4.1 mnol/ 1)
`and hyperglycemia (20.1 mnol/ 1) without ketosis. Plasma sodium and renal function were normal
`and hematosis without hypoxemic alteration.
`
`insulin therapy) and the etiological
`Symptomatic treatment was continued (alkalization,
`assessment entailing toxicological analysis (salicylates, phenothiazines, tricyclics, benzodiazepines,
`carbamates), search for a cerebrovascular accident (brain CT scan and cerebral angiography) and
`infectious assessments (lumbar puncture and bacteriological samples) proved negative.
`
`In the middle of the night, i.e., 10 hours after her admission, she was observed to return to a
`satisfactory state of consciousness with a discrete persistent agitation. In the morning of April 6,
`1990 (16 hours after admission), she was extubated. The neurological examination was then fully
`normal.
`
`She left the Pediatric ICU Department; her parents then brought us an unidentified pill found in
`her room.
`
`Mass spectrometry analysis identified flumequine with a concentration of 61 mg/l (bacterial
`assay) in the blood sample taken at the peak of the clinical symptoms (in chromatographic assay,
`taking 400 mg revealed a peak plasma concentration of 16.9 mg/l).
`
`

`

`J.-F. Defoin et al.
`
`471
`
`This young girl left the Pediatric Department after an electroencephalogram formally excluded
`an underlying epileptic condition and after a medical interview confirmed the ingestion of five
`tablets of flumequine.
`
`COWENTS
`
`The literature reports several cases of fiumequine intoxication with massive doses taken in a
`suicide attempt (2-3-5) or a mere overdose (1-5); this has occurred most often among young patients
`under the age of 30.
`
`In hindsight, the clinical and laboratory picture appears pathognomonic for acute fiumequine
`overdoses that generally combine neuropsychiatric signs, metabolic acidosis, hyperventilation,
`disorders of glucose regulation with or without ketosis, and frequent vomiting.
`
`The treatment of these intoxications is symptomatic (anticonvulsants, alkalization, insulin
`therapy, mechanical ventilation) and the outcome is most often quickly favorable without any
`sequelae.
`
`Our observation is in agreement with the data in the literature, although vomiting and ketosis
`are absent here.
`
`However, it serves to draw attention to several points:
`
`the need for a minimum biological assessment in the face of any acute psychiatric picture
`-
`with a brutal onset,
`
`assistance in the diagnosis represented by a painstaking inquiry, particularly in the
`-
`patient’s relations, for medications or toxins in the face of unexplained clinical pictures,
`
`-
`
`-
`
`the unquestionable contribution of mass spectrometry for identification purposes,
`
`the low therapeutic index and extreme individual sensitivity to this therapeutic class.
`
`further
`is
`(4-5-6),
`already underscored by previous publications
`latter point,
`This
`corroborated by this new case with the taking of a dose equivalent to a double daily dose; however,
`a plasma concentration nearly four times normal (16.9 mg/l after 400 mg for a chromatographic
`assay) was observed. The other cases identified by our Poison Control Center confirm these data.
`
`Indeed, since 1983, ten other cases were identified; five were symptomatic with the presence
`of neuropsychiatric signs for ingested doses ranging from 1.6 to 8 grams.
`
`Aside from these signs, no other symptoms were observed; it is also noted that a dose of 2.4
`grams taken by a 17-year-old girl did not cause any problem.
`
`

`

`472
`
`Acute Psychiatric Syndrome and Quinolones
`
`C0NCL USION
`
`A minimum laboratory assessment and careful questioning of the patient’s relations appear
`indispensable in the face of any acute psychiatric picture with a brutal onset in an individual
`previously free of any disorder.
`
`Likewise, strict compliance with the doses and their daily distribution, as well as an
`adaptation of these doses to the circumstances, are indispensable.
`
`Renewed attention appears necessary with the marketing of new quinolones that might lead
`to such side effects according to individual susceptibilities, all the more so since some of them
`benefit from special administration methods (single dose).
`
`REFERENCES
`
`1. ARNAUDO J.P., MAHEUT H., MARTIN B., HESSE J.Y.: Ketoacidosis
`and
`Hyperglycemia Reversible After Absorption of Flumequine. Role of High Doses in Non-
`Diabetic Adults. Presse Med, 1980, 9, 636.
`
`2. BOLES JM GENTRIC A, GARRE M., COCHARD G, PERNEZ C, SCHEYDECKER J .L.:
`Massive Flumequine Intoxication. Presse Med, 1985, 14, 1668.
`3. COCHARD G, PERNEZ C, ROUE G, BOLES JM GENTRIC A, SCHEYDECKER J .L.:
`On a New Case of Flumequine Intoxication. Conv. Med, 1984, 3, 439-440.
`4. GALLAND M.C., DUPUY F, LULLE J.B., JOUGLARD J.: Flumequine and Central
`Secondary Effects. B. Med Le’gale el T0xic0., 1979, 22, 615-617.
`5. GALLAND M.C., JOUVE-BESTAGNE MH. RODOR F, JOUGLARD J.: Undesirable
`Neurological Effects of Urinary Antibacterial Quinolones. The’rapie 1982, 37, 481-487.
`6. HANNEDOUCHE T, GODIM M., FILLASTRE J.P.: The Side Effects of Medications
`Used for the Treatment of Urinary Infections. The’rapie 1983, 38, 281-293.
`
`SHORT NOTE
`
`Concours Medical — 37 rue de Bellefond — 75441 Paris Cedex 09
`
`[267]
`
`January 19, 1991
`
`During the proceedings of the SOCIETE FRANCAISE DE MEDECINE PREVENTIVE ET SOCIALE
`[“French Society of Preventive and Social Medicine”] (November 24, 1990), Albert HIRSCH showed
`the difficulties of changing collective mindsets when it comes to tobacco.
`
`He pointed out that this sector employs 6,000 to 7,000 persons, produces 25 to 30 billion francs
`a year for the Ministry of Budget, advertisers today devote nearly a billion francs a year to tobacco,
`and it shows the difficulty of communicating a general idea of public health to the general public.
`
`

`

`yndigo translations
`709 Carroll Street
`
`Brooklyn, NY 11215
`Phone: 347-223-4334
`
`yndigotranslations.com
`
`STATE OF NEW YORK )
`) ss
`)
`
`COUNTY OF KlNGS
`
`CERTIFICATE OF ACCURACY
`
`l hereby certify that the attached is, to the best of my knowledge, ability and belief, a true
`and complete translation from French to English of the Journal Article tit/ed "Syndrome
`psychiatrique aigu et quinolones” by J.-F. DEFOIN et al. appearing in Journal de
`Toxicologie Clinique etExpérimenta/e, 1990, T. 10, No. 7—8— 469-472.
`
`Glenn Cain
`President
`
`Yndigo Translations
`
`Subscribed and sworn to before me this g” day ofm , 2013.
`
`
`
`otary Public
`My Commission Expires: fig] 0%]WE
`
`DAVID SZETO
`Notary Public, State of New York
`Qualified in Kings County
`Reg No. 01826245871
`My Commission Expires 08-08-2015
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket